Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Update

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was the target of a large decrease in short interest in January. As of January 31st, there was short interest totalling 5,510,000 shares, a decrease of 6.9% from the January 15th total of 5,920,000 shares. Based on an average daily trading volume, of 1,570,000 shares, the short-interest ratio is currently 3.5 days.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ACHC. State Street Corp increased its holdings in Acadia Healthcare by 3.5% in the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after buying an additional 95,613 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after buying an additional 454,044 shares in the last quarter. SG Americas Securities LLC grew its holdings in Acadia Healthcare by 713.3% in the 4th quarter. SG Americas Securities LLC now owns 110,866 shares of the company’s stock worth $4,396,000 after buying an additional 97,235 shares in the last quarter. LMR Partners LLP bought a new position in Acadia Healthcare in the 3rd quarter worth approximately $1,616,000. Finally, Sivik Global Healthcare LLC lifted its position in Acadia Healthcare by 43.7% in the third quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock worth $7,292,000 after purchasing an additional 34,997 shares during the period.

Acadia Healthcare Trading Up 0.1 %

Shares of ACHC opened at $41.09 on Wednesday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare has a 12 month low of $36.50 and a 12 month high of $87.77. The stock’s 50-day moving average is $42.12 and its two-hundred day moving average is $53.45. The stock has a market cap of $3.82 billion, a PE ratio of 13.47, a P/E/G ratio of 1.75 and a beta of 1.30.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price for the company in a research note on Tuesday, January 7th. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. TD Cowen lowered their price objective on Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. StockNews.com downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price target for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $70.22.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.